Repotrectinib highly active in ROS1-positive lung cancer

ByoungChul Cho

Department of Internal Medicine

Press/Media: Press / Media

Period	2019 Jun 6 → 2019 Jun 7

Media coverage

3

Media coverage

Title	Repotrectinib highly active in ROS1-positive lung cancer
Media name/outlet	MDedge Hematology and Oncology
Country/Territory	United States
Date	19/6/7
URL	https://www.mdedge.com/hematology-oncology/article/202479/lung-cancer/repotrectinib-highly-active-ros1-positive-lung-cancer
Persons	ByoungChul Cho

Title	Repotrectinib highly active in ROS1-positive lung cancer
Media name/outlet	MedicalHealthNews.net
Country/Territory	Turkey
Date	19/6/7
URL	www.medicalhealthnews.net/repotrectinib-highly-active-in-ros1-positive-lung-cancer
Persons	ByoungChul Cho

Title	Repotrectinib highly active in ROS1-positive lung cancer
Media name/outlet	Clinician Reviews
Country/Territory	United States
Date	19/6/6
URL	https://www.mdedge.com/content/repotrectinib-highly-active-ros1-positive-lung-cancer
Persons	ByoungChul Cho